JPC
ELV icon

Jabodon PT Co’s Elevance Health ELV Stock Holding History

Jabodon PT Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,334
Closed -$1.24M – 22
2019
Q1 		$1.24M Buy
+4,334
New +$1.25M 1.05% 21
2018
Q4 		– Sell
-14,551
Closed -$3.99M – 26
2018
Q3 		$3.99M Sell
14,551
-1,034
-7% -$268K 5.19% 5
2018
Q2 		$3.71M Buy
+15,585
New +$3.61M 3.36% 12

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Jabodon PT Co's ELV Position: Q2 2019 in Review

Jabodon PT Co sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 4,334 shares — an estimated $1.24M sold.

Jabodon PT Co first reported a position in ELV in Q2 2018 and held it in 3 quarters. The position peaked at $3.99M in Q3 2018. 1,030 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

  • Jabodon PT Co reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
  • Jabodon PT Co sold 4,334 Elevance Health shares in Q2 2019, an estimated $1.24M.
  • Jabodon PT Co first reported a position in Elevance Health in Q2 2018 and held it in 3 quarters.
  • Jabodon PT Co's Elevance Health position peaked at $3.99M in Q3 2018.
  • 1,030 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on Jabodon PT Co's 13F filing for Q2 2019, filed 7 Aug 2019.